Complement (C3 & C4)

Description: 
The complement system is a protein cascade of 30 enzymes and activator and control proteins, two-thirds of which circulate in the plasma while the remainder are present on cell and tissue surfaces. Complement levels may increase following trauma or inflammation as part of the acute phase response. Complement consumption can also take place in certain disease states, and complement concentration can be useful in diagnosis and monitoring progress. Low concentrations indicate increased consumption or decreased synthesis.

C3 and C4 levels are useful in the management of patients with renal disease, inflammatory joint disease, and multi-system disorders with evidence of vasculitis. A low complement concentration would suggest an immunological basis for the symptoms. C3 and C4 concentrations are often low inactive SLE and cryoglobulinaemia.

Persistently low C3 in glomerulonephritis suggests the presence of C3 nephritic factor and in haemolytic uraemic syndrome Factor H deficiency.
C4 is decreased in hereditary and acquired C1 inhibitor deficiency.
Complement studies are indicated in individuals with recurrent pyogenic septicaemia/meningitis.
Reference range: 

The normal ranges of C3 and C4 do not alter with age.
C3 - 0.70 - 1.65
C4 - 0.16 - 0.54

Units: 
g/L
Sample type and Volume required: 
Clotted (Gold top vacutainer)
EDTA plasma also accepted
Turnaround time: 
2 working days
Special sample instructions: 

All tests are compromised by prolonged transit times. For this reason, date of bleed and date of postage must be provided with each request.

Storage and transport: 
Samples may be stored at 4°C prior to analysis
Time limit for extra tests: 
10 days
Contacts:
Diagnostic Immunology and Allergy Department at King's College Hospital
General Enquiry : 020 3299 8752 / 020 3299 1171
King's College Hospital
Bessemer Wing - 1st Floor
Denmark Hill
London SE5 9RS
For clinical advice or interpretation of results, please contact the laboratory in the first instance.

Print as a PDF

Last updated: 04/01/2021